Amgen (AMGN) Inventory Average (2009 - 2026)

Amgen has reported Inventory Average for 17 years, with the latest figure at $6.2 billion in Q2 2026.

• On a quarterly basis, Inventory Average fell 6.81% year-over-year to $6.2 billion in Q2 2026; TTM through Jun 2026 was $6.2 billion, a 6.81% decrease from a year earlier, with the FY2025 full-year figure at $6.6 billion, down 19.94% from the prior year.
• Inventory Average was $6.2 billion for Q2 2026 at Amgen, roughly flat from $6.2 billion in the prior quarter.
• The five-year high for Inventory Average was $9.1 billion in Q1 2024, with the low at $4.2 billion in Q1 2022.
• Average Inventory Average over 5 years is $6.2 billion, with a median of $6.2 billion recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: Inventory Average surged 83.5% in 2024, then retreated 24.75% in 2025.
• Over 5 years, Inventory Average stood at $4.8 billion in 2022, then surged by 50.14% to $7.3 billion in 2023, then declined by 1.27% to $7.2 billion in 2024, then retreated by 12.46% to $6.3 billion in 2025, then fell by 1.31% to $6.2 billion in 2026.
• The last three Inventory Average figures came in at $6.2 billion (Q2 2026), $6.2 billion (Q1 2026), and $6.3 billion (Q4 2025), per Business Quant data.